- Home
- ASRT
as 04-18-2025 1:31pm EST
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | LAKE FOREST |
| Market Cap: | 65.7M | IPO Year: | 1997 |
| Target Price: | $3.08 | AVG Volume (30 days): | 480.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.51 - $1.80 | Next Earning Date: | 05-05-2025 |
| Revenue: | $124,961,000 | Revenue Growth: | -17.83% |
| Revenue Growth (this year): | -5.93% | Revenue Growth (next year): | 11.20% |
Latest Assertio Holdings Inc. News
ASRT Breaking Stock News: Dive into ASRT Ticker-Specific Updates for Smart Investing
ACCESS Newswire
a month ago
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
GlobeNewswire
a month ago
Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
Simply Wall St.
a month ago
Assertio Holdings Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Thomson Reuters StreetEvents
a month ago
Q4 2024 Assertio Holdings Inc Earnings Call
GuruFocus.com
a month ago
Assertio Holdings Inc (ASRT) Q4 2024 Earnings Call Highlights: Strategic Growth Amidst Challenges
Associated Press Finance
a month ago
Assertio: Q4 Earnings Snapshot
GlobeNewswire
a month ago
Assertio Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
a month ago
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
Compare ASRT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ASRT Assertio Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.